Article Sidebar

Published: 2026-08-14
Abstract Views: 0
DOI: https://doi.org/10.52163/yhc.v67iCD12.6155
Issue
Tập 67 Số CĐ12- HNKH Bệnh viện Ung bướu Nghệ An
Section
Articles
How to Cite
Thư, N. T., Văn, N. A., Nhất, Đào A., Long, N. T., Giang, P. T., Anh, H. H. Q., & Trung, N. K. (2026). ĐÁNH GIÁ KẾ HOẠCH XẠ TRỊ TOÀN NÃO BẢO TỒN HỒI HẢI MÃ BẰNG KỸ THUẬT XẠ TRỊ ĐIỀU BIẾN LIỀU TRÊN PHẦN MỀM MONACO TẠI BỆNH VIỆN UNG BƯỚU NGHỆ AN. Vietnam Journal of Community Medicine, 67(CD12). https://doi.org/10.52163/yhc.v67iCD12.6155

ĐÁNH GIÁ KẾ HOẠCH XẠ TRỊ TOÀN NÃO BẢO TỒN HỒI HẢI MÃ BẰNG KỸ THUẬT XẠ TRỊ ĐIỀU BIẾN LIỀU TRÊN PHẦN MỀM MONACO TẠI BỆNH VIỆN UNG BƯỚU NGHỆ AN

Nguyen Thi Thu1, Nguyen Anh Van2, Dao Anh Nhat1, Nguyen Thang Long1, Pham Thi Giang1, Ho Hoang Quoc Anh1, Nguyen Khac Trung1
1 Department of Radiation Physics, Nghe An Oncology Hospital
2 Department of Head and Neck Radiotherapy, Nghe An Oncology Hospital

Main Article Content

Abstract

Objective: To evaluate the quality of hippocampal-avoidance whole-brain radiotherapy (WBRT-HA) treatment plans using intensity-modulated radiotherapy (IMRT) at Nghe An Oncology Hospital.


Subjects and Methods: This retrospective descriptive study included 31 radiotherapy treatment plans from 31 patients with brain metastases treated with WBRT-HA between January 2021 and December 2025. Treatment plans were generated using the Monaco treatment planning system with 6 MV photon beams, the Monte Carlo dose calculation algorithm, and a prescribed dose of 30 Gy delivered in 10 fractions. Evaluated dosimetric parameters included PTV coverage (V95%, D98%, and D2%), homogeneity index (HI), conformity index (CI), doses to the hippocampus and organs at risk, monitor units (MU), and beam delivery time.


Results: All treatment plans met the prescribed dose distribution criteria, with the mean dose (Dmean) and maximum dose (Dmax) to the PTV of 30.4 ± 0.7 Gy and 33.8 ± 0.8 Gy, respectively. The V95%, D98%, and D2% values were 96.4 ± 1.8%, 28.5 ± 0.8 Gy, and 32.7 ± 0.7 Gy, respectively. The mean HI and CI were 0.14 ± 0.03 and 0.78 ± 0.05, respectively. The mean and maximum hippocampal doses were 9.8 ± 1.2 Gy and 16.8 ± 0.9 Gy, respectively, meeting the RTOG 0933 dose constraints. The maximum dose to both lenses was below 6 Gy. The average number of monitor units was 1794 ± 380 MU, with a mean beam delivery time of 179.4 ± 38 seconds.


Conclusion: IMRT enables the development of hippocampal-avoidance whole-brain radiotherapy (WBRT-HA) plans that meet the RTOG 0933 dose constraints, provide adequate target volume coverage, and reduce radiation dose to the hippocampus and other organs at risk. These findings demonstrate the feasibility of this technique for treatment planning using the Monaco treatment planning system.

Article Details

Keywords

Radiotherapy, Hippocampal-avoidance whole-brain radiotherapy; WBRT-HA; IMRT; hippocampus.

References

1. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. Journal of neuro-oncology. 2005;75(1):5-14.
2. Bhambhvani HP, Granucci M, Rodrigues A, Kakusa BW, Gephart MH. The primary sites leading to brain metastases: Shifting trends at a tertiary care center. Journal of Clinical Neuroscience. 2020;80:121-124.
3. Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. Journal of Clinical Oncology. 2014;32(34):3810-3816.
4. Liu R, Gong G, Meng K, Du S, Yin Y. Hippocampal sparing in whole-brain radiotherapy for brain metastases: controversy, technology and the future. Frontiers in Oncology. 2024;14:1342669.
5. Gregoire V, Mackie T, De Neve W, et al. ICRU Report 83: prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). J ICRU. 2010;10(1):1-106.
6. Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Journal of neurosurgery. 2000;93(supplement_3):219-222.
7. Brown PD, Gondi V, Pugh S, et al. Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001. Journal of Clinical Oncology. 2020;38(10):1019-1029.
8. Thach LB, Thao MT, Nghia NV, et al. Hippocampal-Avoidance Whole-Brain Radiotherapy: Dosimetric Comparison of 3D-CRT, IMRT, and VMAT for Brain Metastases from Lung Cancer. Cancers. 2025;17(23):3744.
9. Wang B-H, Hua W, Gu X, et al. Dosimetric study of different radiotherapy planning approaches for hippocampal avoidance whole-brain radiation therapy (HA-WBRT) based on fused CT and MRI imaging. Australasian physical & engineering sciences in medicine. 2015;38(4):767-775.
10. Li J, Tang X-B, Wang B-H, Chen X-M, Chen D, Chai L. Comparison between Dual Arc VMAT and 7F-IMRT in the protection of hippocampus for patients during whole brain radiotherapy. Journal of X-ray Science and Technology. 2016;24(3):457-466.
11. Gondi V, Tolakanahalli R, Mehta MP, et al. Hippocampal-sparing whole-brain radiotherapy: a “how-to” technique using helical tomotherapy and linear accelerator–based intensity-modulated radiotherapy. International Journal of Radiation Oncology* Biology* Physics. 2010;78(4):1244-1252.